Medical Oncologist
Your treatment plan
Neoadjuvant endocrine therapy: tablets before surgery
For hormone sensitive cancers, tablets taken for several months before surgery can shrink the tumour enough to allow a smaller operation. It works more slowly than chemotherapy and is far gentler to live with, and it only works where the cancer carries hormone receptors. This page explains who it suits and what counts as success.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
The short answer
Can tablets shrink a breast cancer before surgery?
Yes, for hormone sensitive cancers. Hormone tablets taken for several months before surgery can shrink the tumour enough to allow a smaller operation. It works more slowly than chemotherapy and is far gentler, and it only works where the cancer carries hormone receptors.
Who it is usually offered to
Most often to older women, or to women whose other health problems make chemotherapy or immediate surgery risky. It is also used where a strongly hormone sensitive cancer is too large for conservation and chemotherapy would add little.
Why chemotherapy is not the automatic choice here
Strongly hormone sensitive, HER2 negative cancers respond slowly and incompletely to chemotherapy. Giving it before surgery in that group often produces disappointing shrinkage for considerable side effects. Tablets can achieve more, with far less cost to daily life.
Who it does not suit
Anyone whose cancer is hormone receptor negative, where the tablets simply do not work. It is also not the right approach where the cancer is growing quickly, or where waiting several months for a response is not safe.
This is a planned treatment, not a way of postponing surgery indefinitely.How it works
What the treatment involves
It is a tablet a day, with regular checks. That is genuinely most of it.
Cutting off the hormone supply
Hormone sensitive cancers grow when oestrogen reaches them. These tablets either block the receptor or reduce how much oestrogen your body makes, so growth slows and the tumour shrinks.
Several months, not weeks
Shrinkage is gradual. Most courses run for several months before surgery, with the response measured along the way. Stopping too early wastes the approach.
Ask how long your course is planned to run.Regular monitoring
Examination and a scan at intervals, to confirm the cancer is shrinking rather than growing. If it is not responding, the plan changes to surgery or to chemotherapy.
Surgery when the time is right
Once the cancer has shrunk as far as it usefully will, or once your team judges the window is right. The tablets usually continue afterwards as your long-term treatment.
Worth asking
- What are we hoping to achieve
- How will we know it is working
- What happens if it does not
Not sure whether this applies to you?
Ask an oncologistSide by side
Tablets before surgery, compared with chemotherapy
Hormone tablets first
Chemotherapy first
A tablet a day at home
Cycles given at a day-care unit
Shrinkage over several months
Shrinkage over weeks to a few months
Joint aches, hot flushes, tiredness
Hair loss, low blood counts, feeling sick
Only works if hormone receptors are present
Works regardless of receptor status
Complete disappearance is uncommon
Complete disappearance is possible, by subtype
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Words you will hear
The vocabulary, in plain language
- Endocrine therapy
- The general name for hormone treatment. Endocrine simply means hormone.
- Neoadjuvant
- Given before surgery. Adjuvant means the same treatment given after.
- Aromatase inhibitor
- A class of tablet that reduces how much oestrogen the body makes after menopause. Commonly chosen for this purpose.
- Receptor positive
- The cancer carries oestrogen or progesterone receptors, which is what makes these tablets work.
- Downstaging
- The cancer shrinking enough to allow a smaller operation than was first planned.
- Ki-67
- A measure of how fast cancer cells are dividing. Sometimes repeated during treatment to check the tablets are working.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Being straight with you
What this approach can and cannot do
It shrinks tumours reliably in the right patients, and it rarely makes them disappear. A complete response is uncommon with tablets, and its absence tells you nothing worrying. Judge this treatment by whether the operation became smaller, not by whether the cancer vanished.
It does not replace surgery
The cancer still has to come out. Tablets alone are occasionally used as the only treatment for women who are too frail for an operation, and that is a different situation with a different goal, which your team will explain plainly if it applies.
Side effects are real, even though it is only a tablet
Joint aches, stiffness, hot flushes and tiredness are common and can be wearing over months. They are not trivial and they are not something to endure silently. Tell your team, because the tablet can often be changed for another.
The evidence base is smaller
This approach is less studied than chemotherapy before surgery, and practice varies more between centres. That is worth knowing when you compare notes with someone treated elsewhere. Ask your oncologist why it was chosen for you.
Commonly believed
What families say when tablets are offered instead
Tablets mean they are not treating her seriously.
For a strongly hormone sensitive cancer, hormone treatment is the most effective tool available, not a lesser one. Chemotherapy in this subtype often produces modest shrinkage for substantial side effects. Choosing the tablets is a clinical judgement about what works.
She is only being given this because of her age.
Age is one factor, and so is the biology of the cancer. Many older women are given chemotherapy where it is warranted. If you think age alone is driving the decision, ask directly what the receptor results were and what the alternatives would offer.
If the lump is not disappearing, it is not working.
Complete disappearance is uncommon with tablets and is not the target. Steady shrinking over months, enough to allow a smaller operation, is exactly the intended result. Ask what the measurements are showing rather than judging by feel alone.
Surgery can be put off indefinitely if the tablets work.
The cancer still needs removing, and the course is planned with a surgical date in mind. Treatment without a planned endpoint is a different situation, used for women who cannot have an operation, and your team would tell you plainly if that were the case.
Questions we are asked
Common questions about tablets before surgery
How long before I see a difference?
Shrinkage is gradual and is usually measured rather than felt. Most teams assess the response after a couple of months and then at intervals. Do not expect the dramatic change some women describe with chemotherapy; steady, modest shrinking is what this treatment is for.
Will I still need chemotherapy afterwards?
Often not, particularly where the cancer is strongly hormone sensitive, the nodes are clear and a gene test suggests little benefit. It depends on what the surgery finds. Ask whether a gene test on the tumour is planned, because it is frequently what settles this question.
What if the cancer grows instead?
Your team will pick it up at the monitoring visits and change the plan, usually to surgery sooner or to chemotherapy. Growth on this treatment is uncommon but it is exactly what the regular checks exist to catch. Report any change you notice yourself without waiting.
Do I keep taking the tablets after surgery?
Usually yes, and for years. The treatment before surgery is the beginning of your long-term hormone therapy rather than a separate course. Ask for the total planned duration in writing, since this is the part people most often stop early.
Are the side effects worse than chemotherapy?
They are different rather than worse. Joint aches, hot flushes, stiffness and tiredness are common and can wear you down over months, but hair loss and low blood counts are not features. Most women find it considerably easier to live with.
Can I have this instead of surgery altogether?
Tablets alone are sometimes used for women who are too frail for an operation, with the aim of controlling the cancer rather than removing it. That is a different plan with a different goal. If you are fit for surgery, the operation remains part of the approach.
Will a gene test help decide?
It may, particularly in deciding whether chemotherapy adds anything for you. Ask whether one applies to your situation, what it costs and what decision it would actually change. A test that changes nothing is not worth the wait or the expense.
Is this approach used in India?
Yes, and it is particularly useful where a woman is older, has other health problems, or faces a wait for surgery. It is less commonly used than chemotherapy before surgery, so practice varies between centres. Ask your oncologist about their own experience.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- Cancer Research UK — Hormone therapy for breast cancer
- National Cancer Institute — Hormone therapy for breast cancer
- Breast Cancer Now — Hormone therapy
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.